We are live on
!
Find out more
Sands Capital Management Portfolio holdings
AUM
$25.5B
1-Year Est. Return
26.46%
This Fund
S&P 500
This Quarter
Est. Return
+11.32%
1 Year Est. Return
+26.46%
3 Year Est. Return
+130.81%
5 Year Est. Return
+100.92%
10 Year Est. Return
+877.17%
AUM
$33.8B
AUM Growth
+$826M
(+2.5%)
Cap. Flow
-$2.17B
Cap. Flow
% of AUM
-6.42%
Top 10 Holdings %
Top 10 Hldgs %
53.63%
Holding
70
New
2
Increased
25
Reduced
37
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Align Technology
ALGN
|
+$696M |
| 2 |
Incyte
INCY
|
+$142M |
| 3 |
Alibaba
BABA
|
+$102M |
| 4 |
Monster Beverage
MNST
|
+$82.3M |
| 5 |
Trip.com Group
TCOM
|
+$21.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$428M |
| 2 |
Biogen
BIIB
|
+$363M |
| 3 |
Booking.com
BKNG
|
+$347M |
| 4 |
Visa
V
|
+$236M |
| 5 |
Amazon
AMZN
|
+$200M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 25.64% |
| 2 | Technology | 21.37% |
| 3 | Communication Services | 20.45% |
| 4 | Healthcare | 16.92% |
| 5 | Financials | 10.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Alibaba
BABA
$274B
| $2.76B | 8.16% |
15,035,820
+541,124
| +4% | +$102M |
|
|
2
Amazon
AMZN
$2.47T
| $2.65B | 7.83% |
36,591,260
-2,795,880
| -7% | -$200M |
|
|
3
Visa
V
$701B
| $2.33B | 6.9% |
19,492,704
-1,951,245
| -9% | -$236M |
|
4
Netflix
NFLX
$301B
| $1.88B | 5.56% |
63,672,650
-4,738,790
| -7% | -$129M |
|
|
5
Meta Platforms (Facebook)
META
$1.51T
| $1.64B | 4.85% |
10,270,691
-2,384,228
| -19% | -$428M |
|
6
Baidu
BIDU
$35.4B
| $1.56B | 4.6% |
6,972,910
-344,838
| -5% | -$85M |
|
7
Salesforce
CRM
$150B
| $1.4B | 4.13% |
11,997,567
-844,703
| -7% | -$97M |
|
|
8
Booking.com
BKNG
$153B
| $1.37B | 4.05% |
16,471,350
-4,418,175
| -21% | -$347M |
|
9
Alphabet (Google) Class A
GOOGL
$4.1T
| $1.3B | 3.85% |
25,102,020
-1,640,000
| -6% | -$90.9M |
|
|
SCHW
10
Charles Schwab
SCHW
$185B
| $1.25B | 3.69% |
23,872,209
-1,559,752
| -6% | -$83.6M |
|
11
ServiceNow
NOW
$114B
| $1.23B | 3.62% |
37,024,940
-3,330,025
| -8% | -$103M |
|
12
Illumina
ILMN
$29.6B
| $1.06B | 3.12% |
4,588,422
-297,146
| -6% | -$68.1M |
|
13
Adobe
ADBE
$100B
| $1.05B | 3.12% |
4,881,949
-469,417
| -9% | -$95.4M |
|
14
Edwards Lifesciences
EW
$48.3B
| $910M | 2.69% |
19,566,492
-1,301,613
| -6% | -$56.5M |
|
15
Regeneron Pharmaceuticals
REGN
$73B
| $828M | 2.45% |
2,404,087
-152,525
| -6% | -$53.1M |
|
|
16
Incyte
INCY
$25.8B
| $814M | 2.41% |
9,768,698
+1,577,411
| +19% | +$142M |
|
17
ASML
ASML
$607B
| $692M | 2.05% |
3,483,137
-222,967
| -6% | -$43.9M |
|
18
Palo Alto Networks
PANW
$258B
| $681M | 2.01% |
22,498,038
-1,277,478
| -5% | -$35.5M |
|
|
19
Align Technology
ALGN
$12.9B
| $681M | 2.01% |
+2,709,813
| New | +$696M |
|
|
20
Monster Beverage
MNST
$96.4B
| $655M | 1.94% |
22,899,192
+2,636,206
| +13% | +$82.3M |
|
21
Starbucks
SBUX
$119B
| $651M | 1.93% |
11,245,074
-648,774
| -5% | -$37.5M |
|
22
Workday
WDAY
$39.8B
| $631M | 1.87% |
4,961,554
-314,395
| -6% | -$38.5M |
|
23
BioMarin Pharmaceuticals
BMRN
$11.9B
| $588M | 1.74% |
7,247,851
-478,927
| -6% | -$41.1M |
|
|
SPLK
24
DELISTED
Splunk Inc
SPLK
| $569M | 1.68% |
5,784,248
-341,235
| -6% | -$32.6M |
|
25
Nike
NKE
$63.3B
| $566M | 1.67% |
8,523,059
-488,950
| -5% | -$32.3M |
|
Similar funds
KK
VAI
UIM
SO
Sands Capital Management's Q1 2018 Portfolio in Review
As of Q1 2018, Sands Capital Management held 70 positions worth $33.8B, up 2.5% from $33B the previous quarter. Its ten largest holdings account for 54% of the portfolio.
Sands Capital Management withdrew a net $2.17B in Q1 2018, closing 3 positions and reducing 37 holdings. Its most notable exit was Biogen, an estimated $363M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 26% of assets, up from 25% a quarter earlier, followed by Technology and Communication Services.
Against the trend, Sands Capital Management opened a new position in Align Technology worth $681M.
- Sands Capital Management's largest Q1 2018 buy was Align Technology: 2,709,813 shares worth $681M.
- Sands Capital Management added most to Incyte in Q1 2018, an estimated $142M increase.
- Sands Capital Management's biggest Q1 2018 reduction was Meta Platforms (Facebook), cutting an estimated $428M.
- Sands Capital Management fully exited Biogen in Q1 2018, selling an estimated $363M.
- Sands Capital Management's ten largest holdings make up 54% of its $33.8B portfolio in Q1 2018.
- Sands Capital Management opened 2 new positions and closed 3 in Q1 2018.
- Sands Capital Management's portfolio value rose 2.5% quarter-over-quarter to $33.8B.
Based on Sands Capital Management's 13F filing for Q1 2018, filed 15 May 2018.